Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 301–320 of 17,529 recalls

September 23, 2025· ACME UNITED CORPORATION

Recalled Item: Sting Relief Swabs

The Issue: Product Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 22, 2025· RC Outsourcing, LLC

Recalled Item: Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 19, 2025· Ascend Laboratories, LLC

Recalled Item: Atorvastatin Calcium Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 19, 2025· Ascend Laboratories, LLC

Recalled Item: Atorvastatin Calcium Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 19, 2025· Ascend Laboratories, LLC

Recalled Item: Atorvastatin Calcium Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 19, 2025· Ascend Laboratories, LLC

Recalled Item: Atorvastatin Calcium Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 17, 2025· Park Avenue Compounding

Recalled Item: Phenylephrine HCI

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 17, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Azelaic Acid Gel

The Issue: CGMP Deviations: Market complaints received for gritty texture

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 16, 2025· IntegraDose Compounding Services LLC

Recalled Item: Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use

The Issue: Subpotent Drug: Testing revealed there was no oxytocin

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
September 16, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Subpotent: During long term stability testing of Levothyroxine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 15, 2025· Graviti Pharmaceuticals Private Limited

Recalled Item: Bupropion Hydrochloride Extended-Release Tablets USP (XL)

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 15, 2025· Amerisource Health Services LLC

Recalled Item: Carbamazepine Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 12, 2025· Letco Medical LLC

Recalled Item: Espumil

The Issue: Labeling: Not Elsewhere Classified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
September 12, 2025· JB Chemicals and Pharmaceuticals Ltd

Recalled Item: Cetirizine Hydrochloride Tablets USP 10 mg

The Issue: Tablet/Capsules Imprinted with Wrong ID

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
September 12, 2025· JB Chemicals and Pharmaceuticals Ltd

Recalled Item: Cetirizine Hydrochloride Tablets USP 10 mg

The Issue: Tablet/Capsules Imprinted with Wrong ID

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
September 12, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Major ChlorproMAZINE Hydrochloride Tablets

The Issue: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 12, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Major ChlorproMAZINE Hydrochloride Tablets

The Issue: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 12, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Major ChlorproMAZINE Hydrochloride Tablets

The Issue: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 12, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Major ChlorproMAZINE Hydrochloride Tablets

The Issue: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
September 12, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Major ChlorproMAZINE Hydrochloride Tablets

The Issue: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund